Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation

Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation

Tendon defects require multimodal therapeutic management over extensive periods and incur high collateral burden with frequent functional losses. Specific cell therapies have recently been developed in parallel to surgical techniques for managing acute and degenerative tendon tissue affections, to o...

Full description

Bibliographic Details
Main Authors: Alexis Laurent, Philippe Abdel-Sayed, Anthony Grognuz, Corinne Scaletta, Nathalie Hirt-Burri, Murielle Michetti, Anthony S. de Buys Roessingh, Wassim Raffoul, Peter Kronen, Katja Nuss, Brigitte von Rechenberg, Lee Ann Applegate, Salim E. Darwiche
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Biomedicines
Subjects:
cell banking
chorioallantoic membrane model
fetal progenitor cell therapy
pilot safety study
preclinical animal model
regenerative medicine
Online Access:https://www.mdpi.com/2227-9059/9/4/380

Internet

https://www.mdpi.com/2227-9059/9/4/380

Similar Items